Fact CheckerSign in

NCT07535398Recruiting

Telerehabilitation in Patients With Elevated Pulmonary Artery Pressure

The Effectiveness of Telerehabilitation in Patients With Elevated Pulmonary Artery Pressure

Source: ClinicalTrials.gov · Last updated 29 Apr 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn if synchronous telerehabilitation is effective in patients with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg). It will also evaluate the effects of telerehabilitation on exercise capacity, dyspnea, fatigue, functional status, and quality of life. The main questions it aims to answer are: Does synchronous telerehabilitation improve exercise and functional capacity in these patients? Does synchronous telerehabilitation improve dyspnea, fatigue, psychological status, and quality of life? Researchers will compare synchronous telerehabilitation with breathing and posture exercises to see if telerehabilitation provides greater clinical and functional benefit. Participants will: Be randomly assigned to one of 2 groups Follow an 8-week program, 3 times per week, for 30 minutes per session Perform aerobic, endurance, and strengthening exercises by synchronous telerehabilitation, or breathing and posture exercises in the control group Complete assessments before and after treatment

Status (registry)
Recruiting
Study type
Interventional
Enrollment
12 (estimated)
First submitted
10 Apr 2026
Start date
Apr 2026
Primary completion date
Jun 2026
Lead sponsor
Marmara University
NCT number
NCT07535398

What you commit to

  • Study type: Interventional
  • Planned participants: 12
  • From Apr 2026 to the primary completion date, Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Requirement for oxygen therapy

Other illness

  • Ongoing treatment for psychiatric or psychological disorders
  • Cognitive impairment based on Mini-Mental State Examination findings
  • Severe chronic obstructive pulmonary disease (COPD)
  • Other significant cardiac disease that may interfere with participation or assessment

Other

  • Musculoskeletal problems limiting participation in exercise

Who the study is looking for

  • Adults aged 18 to 65 years
  • Elevated pulmonary artery pressure identified by echocardiography, defined as systolic pulmonary artery pressure (sPAP) of 50 mmHg or higher
  • Clinically stable and receiving medical treatment under cardiology follow-up World Health Organization functional class I or II
  • New York Heart Association (NYHA) functional class I or II
  • Living with a caregiver, family member, or another person who can provide assistance if needed
  • Access to the internet and adequate visual, cognitive, and functional ability to participate in videoconference-based sessions
  • Willing to participate and able to provide informed consent

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tokat Gaziosmanpaşa University
Coordinator of this site? Confirm its status
Tokat ProvinceTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.